It’s a development millions of people living with Type 1 diabetes never thought would happen. A new study is showing promising a functional cure for the life-long disease.

Teplizumab, also known as Tzield and made by Sanofi, is approved for children aged 8 and over and adults who have early-stage type 1 diabetes before symptoms appear. It has been proven to slow down ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...

Type 1 diabetes occurs when the pancreas does not function properly, making the body unable to process sugars. Many people manage it with medication, insulin injections, and diet. However, if a person ...

A new consensus report on the management of type 1 diabetes in adults was presented recently at the European Association for the Study of Diabetes (EASD) meetings. This is an EASD/American Diabetes ...

Teplizumab is an immunotherapy drug designed to modify the immune system's response. Instead of simply treating symptoms, it ...

Once known as “juvenile” diabetes, type 1 diabetes was long considered a childhood disease. Although the condition is often diagnosed in children and teenagers, it can develop at any age. Type 1 ...

While it has long been known that type 1 diabetes runs in families, experts are less certain about what actually starts the autoimmune attack that defines the disease. Most people with type 1 diabetes ...

Insulin has been the mainstay of Type 1 diabetes treatment for years now, assisting individuals in controlling the disease ...